ABCC2 and metabolic dysfunction-associated steatohepatitis: Oatp1a4 protein expression increased to 327% of control in the WT-NASH group, to 806% of control in the Mrp2–/–-NASH group, and was not detected in Oatp1a/1b cluster knockout animals (Fig. 5A and B, upper right panels).